SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TGEN - Targeted Genetics Corporation -- Ignore unavailable to you. Want to Upgrade?


To: Mike McFarland who wrote (268)3/1/2000 12:19:00 PM
From: Cheryl GaltRespond to of 557
 
> these so-called premium type investors were not
stepping up to the plate when they were really needed <

Of course institutional investors stay away when they are NEEDED!!!!

They come when they plan to reap rewards, at attractive risk.

> 30M seems small compared to the CURRENT marketcap of Tgen <

But not so small compared to its market cap on Feb 1st.

> Well, seems like they should have gone for a lot more cash,
this is a little weak in my humble opinion. I WILL NOT
hang on to my remaining shares. ... I will repurchase my shares if I can get them closer to
$14 in the weeks or months ahead. Always dips...well
almost always, heheh. <

Oh no! Mike!! Deja vu. Remember Ariad ...
Count to 10. Get some sleep. Play with the baby ...

Meanwhile, I'm glad you posted your frank reaction, so we can bounce it around. First I want to look at the market a while, then I'll sort out and type my response. (But hint: I'm satisfied with this step.)

TGEN at 23 3/8 on almost a million shares at this moment ...
But I'll celebrate if we get another buying opportunity in the near future. (My boys just cashed their graduation present bonds from Grandma -- so missed earlier buy chances.)

Regards,
Cheryl



To: Mike McFarland who wrote (268)3/1/2000 12:21:00 PM
From: Michael BakuninRead Replies (1) | Respond to of 557
 
I don't love this move either, but these placements have not been uncommon lately; usually, like you, I punt most of my shares in response. In TGEN's case, I've already whittled off most of my position (on the 40% HIV-press release spike). Given the lunacy in the market these days, I'm holding a little just-in-case position, but I look forward to the inevitable dip, whether next week or next year. -mb FD: I sold lots of TGEN and ARIA way below current prices, too. There's no shame in taking gains like those.